<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><link rel="EditURI" type="application/rsd+xml" title="RSD" href="../xmlrpc%3Frsd" />
<script type="text/javascript" src="http://static.mihanblog.com//public/scripts/run/g.other.v3.js"></script>
<script>

	function c_$(id){
        return document.getElementById(id);
    }
    
			//if (parent.frames.length) top.location.href= document.location;
		
	setTodayDate = function(){
		document.write('پنجشنبه 27 آذر 1399');
		/*1508136*/	}

</script>



        <script type="text/javascript">
            (function(){
            var now = new Date();
            var head = document.getElementsByTagName('head')[0];
            var script = document.createElement('script');
            script.async = true;
            var script_address = 'https://cdn.yektanet.com/js/mihanblog.com/native-mihanblog.com-6531.js';
            script.src = script_address + '?v=' + now.getFullYear().toString() + '0' + now.getMonth() + '0' + now.getDate() + '0' + now.getHours();
            head.appendChild(script);
            })();
        </script>

        <!--<script type="text/javascript">
            var head = document.getElementsByTagName("head")[0];
            var script = document.createElement("script");
            script.type = "text/javascript";
            script.async=1;
            script.src = "https://s1.mediaad.org/serve/mihanblog.com/loader.js" ;
            head.appendChild(script);
        </script>-->
        
        <script>
            var sabaVisionWebsiteID = "9bab9dac-041d-4bdb-b39a-1ed789f65eed"; var sabaVisionWebsitePage = "ALL"
        </script>
        <link rel="stylesheet" href="https://plus.sabavision.com/dox/dox.min.css">
        <script src="https://plus.sabavision.com/dox/dox.min.js"></script>
        
        <script>
	linkdailyForm = function(){
		try{
			window.open('/linkdaily/new','linkdaily','status=yes,scrollbars=yes,toolbar=no,menubar=no,location=no ,width=500px,height=460px');
		} catch(e){}
	}
</script><script>

	statInfo = new Array();
	setStatVar = function(index,value){
		statInfo[index] = value;
	}
	getStatVar = function(index){
		if(statInfo[index]) document.write(statInfo[index]);
	}
	
	setStatVar('total_post','440');
	setStatVar('total_author','0');
	setStatVar('modify_date','جمعه 23 شهریور 1397');
	
	setStatVar('today_view','33');
	setStatVar('yesterday_view','35');
	
	setStatVar('this_month_view','1629');
	setStatVar('last_month_view','1132');

	setStatVar('total_view','202111');
	setStatVar('last_view_date','پنجشنبه 27 آذر 1399 (16:27)');



    
</script><script>
	messageForm = function(post_id){
		try{
			window.open('/message','message','status=yes,scrollbars=yes,toolbar=no,menubar=no,location=no ,width=480px,height=550px');
		} catch(e){}
	}
</script><script>
	try{
		var commentCnt = new Array();
		commentCnt[3]='5';	} catch(e){}
	
	newComment = function(post_id){
		try{
			window.open('/post/comment/'+post_id,'comment','status=yes,scrollbars=yes,toolbar=no,menubar=no,location=no ,width=480px,height=540px');
		} catch(e){}
	}
	setCommentCnt = function(post_id){
		try{
			if(commentCnt[post_id]){
				document.write(commentCnt[post_id]);
			} else {
				document.write(0);
			}
		} catch(e){}
	}
</script>
    <style>
        @font-face {
            font-family: 'Mihan-Iransans';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'Mihan-IransansBold';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-Black.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-Black.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-Black.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-Black.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-Black.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'Mihan-IransansLight';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-UltraLight.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-UltraLight.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-UltraLight.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-UltraLight.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Iransans-UltraLight.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'Mihan-Nassim';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Nassim.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Nassim.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Nassim.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Nassim.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Nassim.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'Mihan-Koodak';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Koodak.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Koodak.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Koodak.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Koodak.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Koodak.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'Mihan-Yekan';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Yekan.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/Yekan.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Yekan.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Yekan.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/Yekan.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }
        @font-face {
            font-family: 'FontAwesome';
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/fontawesome_webfont.eot');
            src: url('http://sookootshab.mihanblog.com/public/public/fonts/fontawesome_webfont.eot?') format('embedded-opentype'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/fontawesome_webfont.woff2') format('woff2'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/fontawesome_webfont.woff') format('woff'),
            url('http://sookootshab.mihanblog.com/public/public/fonts/fontawesome_webfont.ttf') format('truetype');
            font-weight: normal;
            font-style: normal;
        }


        

        /* Smartphones (portrait and landscape) ----------- */

        /*
        @media only screen and (max-width : 480px) and (min-width : 320px) {
            .sabaClick_advert__wrapper{
                display:block;
            }
            .sabaClick_advert__inner{
                max-width: 90%;
                margin: 0 5%;
            }
        }
        */

    </style>






<html xmlns="http://www.w3.org/1999/xhtml">
<head>




 <script type="text/javascript">(function(ti) { var ti_id = 'ti_' + ~~(Math.random() * 999999), ti_url = location.protocol + '//tabligheirani.com/showad/?webid=1dc76d2e2f98fd1275226368f76f59d3&s=3&fix=1&locid='+ti_id; ti.write('<div id="' + ti_id + '" style="display: inline-block"></div>'); ti.write('<script type="text/javascript" src="'&#32;+&#32;ti_url&#32;+&#32;'.html" async></scri' + 'pt>'); })(document);</script> 


 <script type="text/javascript">(function(ti) { var ti_id = 'ti_' + ~~(Math.random() * 999999), ti_url = location.protocol + '//tabligheirani.com/showad/?webid=1dc76d2e2f98fd1275226368f76f59d3&s=3&fix=2&locid='+ti_id; ti.write('<div id="' + ti_id + '" style="display: inline-block"></div>'); ti.write('<script type="text/javascript" src="'&#32;+&#32;ti_url&#32;+&#32;'.html" async></scri' + 'pt>'); })(document);</script> 


 <script type="text/javascript">(function(ti) { var ti_id = 'ti_' + ~~(Math.random() * 999999), ti_url = location.protocol + '//tabligheirani.com/showad/?webid=1dc76d2e2f98fd1275226368f76f59d3&s=3&fix=3&locid='+ti_id; ti.write('<div id="' + ti_id + '" style="display: inline-block"></div>'); ti.write('<script type="text/javascript" src="'&#32;+&#32;ti_url&#32;+&#32;'.html" async></scri' + 'pt>'); })(document);</script> 

 <script type="text/javascript">(function(ti) { var ti_id = 'ti_' + ~~(Math.random() * 999999), ti_url = location.protocol + '//tabligheirani.com/showad/?webid=1dc76d2e2f98fd1275226368f76f59d3&s=3&fix=4&locid='+ti_id; ti.write('<div id="' + ti_id + '" style="display: inline-block"></div>'); ti.write('<script type="text/javascript" src="'&#32;+&#32;ti_url&#32;+&#32;'.html" async></scri' + 'pt>'); })(document);</script> 



<script type="text/javascript">(function(ti) { var ti_id = 'ti_' + ~~(Math.random() * 999999), ti_url = location.protocol + '//tabligheirani.com/showad/?webid=1dc76d2e2f98fd1275226368f76f59d3&box=1&locid='+ti_id; ti.write('<div id="' + ti_id + '" style="display: inline-block"></div>'); ti.write('<script type="text/javascript" src="'&#32;+&#32;ti_url&#32;+&#32;'.html" async></scri' + 'pt>'); })(document);</script>


<script type="text/javascript">
var wideads_user_id = 113; 
var script = document.createElement('script');
script.src = ('https:' == document.location.protocol ? 'https://' : 'http://') + 'wideads.com/website/js';
script.type = 'text/javascript';
var hd = document.getElementsByTagName('head')[0];
hd.appendChild(script);
</script>


  
<meta name="google-site-verification" content="O_2WIRX1KhvVJLOrgxB0sYuaaJ7vlsSF3jOOCOYkYCA" />
<meta name="google-site-verification" content="SNalyMhB-pN10jdqVkVnxstKiiiGK5XzIpNZwivlEkU" />
<meta name="google-site-verification" content="Y3SG1g5mVPinIITCzgwdiYIZadcPp_E6fbY-g1V0GXI" />
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="description" content=" لیزر حرارتی اصل"/>
<meta name="keywords" content=",لیزر,حرارتی,اصل,"/>

<link rel="alternate" type="application/rss+xml" title="گیره کوچک کننده بینی خوبه" href="rss/index.html" />
<link rel="alternate" type="application/atom+xml" title="گیره کوچک کننده بینی خوبه" href="atom/index.html" />

<title>گیره کوچک کننده بینی خوبه -  لیزر حرارتی اصل</title>
<style type="text/css">
body{
    background:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/gradient.jpg") repeat-x scroll 0 0 #4A7BB5;
    color:#333333;
    font-family:"Tahoma",Arial;
    font-size:12px;
    line-height:20px;
    margin-bottom:20px;
    direction:rtl;
}
a img{
    border:none;
}
    /* ***************************************************************************** CLEAR FIX  */
.clearfix {display: inline-block;}
.clearfix:after {
    content: ".";
    display: block;
    height: 0;
    clear: both;
    visibility: hidden;
}
    /* Hides from IE-mac \*/
* html .clearfix {height: 1%;}
.clearfix {display: block;}
    /* End hide from IE-mac */
    /* ************************************************************************** EO CLEAR FIX   */
.wrapper{
    margin:60px  auto;
    width:950px;
}

a{
    color:#355880;
    text-decoration:none;
}
img{
    max-width : 580px;
}
a:hover{
    color:#333333;
}
.header{
    height:52px;
}
.navigation{
    height:19px;
    margin-bottom:-1px;
    padding-right:10px;
}
.navigation a{
    background:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/menuleft.jpg") no-repeat scroll left top #FFFFFF;
    border-right:2px solid #000000;
    display:inline;
    margin-right:5px;
    padding:3px 14px 1px 15px;
    color:#34577F;
    font-weight:bold;
    text-decoration:none;
}
.topborder{
    background:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/topper.jpg") no-repeat scroll center bottom transparent;
    height:9px;
    width:950px;
}
.wrapper2{
    background-color:#FFFFFF;
    margin:auto;
    width:950px;
}
.header{
    background-color:#A0C772;
    background-image:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/header.jpg");
    background-repeat:no-repeat;
    height:160px;
    margin:auto;
    padding:0;
    width:930px;
}
.header h1{
    margin:0;
    padding:15px 15px 10px 10px;
    width:600px;
    overflow:hidden;
}
.header h1 a{
    color:#fff;
}
.slogan{
    padding-right:15px;
    width:500px;
    overflow:hidden;
    color:#fff;
}
.content{
    margin:auto;
    width:930px;
}
.left{
    background-color:#F4F4F4;
    border:1px solid #E8E8E8;
    float:left;
    margin-right:10px;
    width:580px;
    padding:10px;
}
.post{
    margin-bottom:30px;
}
.post h2 a{
    border-bottom:3px solid #4A7BB5;
    color:#333333;
    font-size:20px;
    font-weight:lighter;
    padding:5px 0 3px;
    text-decoration:none;
}
.post h2 a:hover{
    color:#000000;
}
.page_box ul{
    direction:rtl;
    height:17px;
    margin:3px auto;
    max-width:460px;
    text-align:left;
    width:390px;
    list-style:none;
}
.page_box ul{
    height:17px;
}
.page_box li{
    float:right;
    margin-right:5px;
    list-style:none;
    background:none;
    color:#444;
    font-family: Tahoma, Arial, Times New Roman;
    font-size: 14px;
}

.page_box a{
    border:1px solid #AAAAAA;
    display:block;
    line-height:17px;
    text-align:center;
    width:17px;
}
.page_box a:hover{
    text-decoration:none;
}
.page_box a b{
    color:#333;
    display:block;
    line-height:17px;
    text-align:center;
    width:17px;
    background-attachment: scroll;
    background-color: #ffffff;
    background-image: none;
    background-repeat: repeat;
    background-position: 0 0;
}
.PostCom{
    background-color:#FFFFFF;
    border:1px solid #E8E8E8;
    font-size:12px;
    padding:5px;
}
.right-top{
    background-color:#F4F4F4;
    border:1px solid #E8E8E8;
    margin-top:10px;
    padding:10px;
    width:290px;
}
.rss{
    background:transparent url(http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/feed.gif) no-repeat scroll right 0;
    padding-right:25px;
    line-height:25px;
    margin-bottom:5px;
}
.text{
    border:1px solid #E8E8E8;
    color:#333333;
    font:14px Arial;
    padding:3px 3px 3px 8px;
    width:150px;
    float:right;
}
.submit{
    margin-right:10px;
    width:80px;
}
.search{
    padding-bottom:10px;
}
.right{
    float:right;
    width:290px;
    margin-top:10px;
    padding:10px;
    background-color:#F4F4F4;
    border:1px solid #E8E8E8;
}
.nav h2{
    color:#333333;
    font-size:16px;
    font-weight:bold;
    padding:5px;
    background-color:#f9f9f9;
    border:1px solid #ececec;
}
.nav h2:hover{
    background-color:#ebebeb;
    border:1px solid #d2d2d2;
}
.nav a{
    border-color:#E3E3E3 -moz-use-text-color -moz-use-text-color;
    border-right:0 none;
    border-style:solid none none;
    border-width:1px 0 0;
    display:block;
    line-height:180%;
    margin:0;
}
.nav a:hover{
    background-color:#fff;
}
.nav{
    margin-bottom:25px;
}
.btmborder{
    background:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/bottom.jpg") no-repeat scroll center top transparent;
    height:9px;
    margin:auto;
    width:950px;
}
.footer{
    background:url("http://mihanblog.com/public//public/user_data/user_files/97/289651/greenblue/footer.jpg") no-repeat scroll center top transparent;
    color:#333333;
    font-size:11px;
    padding:0 5px 5px;
    text-align:center;
}
.footer p{
    margin:0;
}



.cblike{
    margin:4px 0px;
}
.cblike a {
    float:left;
    padding:3px;
    text-align:center;
    font-size:12px;
    color:#FFF;
    display:block;
    line-height:15px;
    text-decoration: none;
}




.cblike a.clike_plus {
    background-color:#009900 ; /*green #039B03*/

    border-radius: 5px ;

    border-top-right-radius: 0px;
    border-bottom-right-radius: 0px;

    /*border:1px solid green;
             border-right:0px;*/
}
.cblike a.clike_minus {
    background-color:#CC0000;
    border-radius: 5px ;
    border-top-left-radius: 0px;
    border-bottom-left-radius: 0px;

    /*border:1px solid red;
             border-left:0px;*/
}
.cblike a.clike_minus:hover {
    background-color:red;
    text-decoration: none;
}
.cblike a.clike_plus:hover {
    background-color:green;
    text-decoration: none;
}
.cblike a span{
    font-weight:bold;
    font-size:13px;

    color:#fff;
}


</style>
</head>
<body>
<div class="wrapper">
<div class="navigation">
    <a class="home-menu" href="../index.html">خانه</a>
    <a href="mailto:" >پست الكترونیك</a>
    <a href="javascript:messageForm()" >تماس با مدیر</a>
    <a href="atom/index.html">Atom</a>

</div>
<div class="topborder"></div>
<div class="wrapper2">
<div class="header clearfix">
    <h1><a href="../index.html" id="logo">گیره کوچک کننده بینی خوبه</a></h1>
    <span class="slogan">گیره کوچک کننده بینی,گیره کوچک کننده بینی خوبه,گیره کوچک کننده بینی نوز آپ,گیره کوچک کننده بینی گوشتی,گیره کوچک کننده بینی خرید,</span>
</div>
<div class="content clearfix">
<div class="left">
		<div id="MihanblogShopAds" style="display:block;height:0px;width:100%;border:0px"></div>
		    <div class="post">
        <h2><a href="3.html"> لیزر حرارتی اصل</a></h2>
        <div class="date clearfix">
            <div style="float:right">نویسنده :<a href="author/1190609.html">مسعود هاشمی</a></div>
            <div style="float:left">تاریخ:چهارشنبه 7 آبان 1393-02:44 ق.ظ</div>
        </div>




        <div class="post-body">
            <p> <div id="InPost_MihanblogShopAds" style="display:block;height:0px;width:100%;border:0px"></div><div align="center">Laser treatment of cutaneal tube lesions has progressed considerably over the past twenty years. supported the pioneering work of Anderson and Maxfield Frederick Parrish within the early Eighties, many vascular-specific optical device systems are developed mistreatment principles of selective photothermolysis.<br><br>Laser irradiation will by selection destroy specific targets (chromophores) among the skin by mistreatment AN acceptable wavelength and pulse period. Pulse period should be but or adequate to the targeted thermal time constant of the radical, ie, the time necessary for the target to cool down by half its peak temperature once optical device irradiation. as a result of the energy deposited within the tissue is proscribed to targeted sites, important thermal diffusion to adjacent skin is prevented. additionally, as a result of wavelengths like absorption peaks for numerous skin chromophores square measure famous, absorption of optical device energy is localized while not damaging neighboring structures. The targeted radical for tube lesions is intravascular oxyhemoglobin; therefore, thermal harm is basically restricted to cutaneal blood vessels.<br><br>Early optical device technology used continuous-wave (CW) mode lasers for treating cutaneal tube lesions. These lasers failed to limit harm to the targeted tube structures, and, consequently, their use resulted during a high prevalence of scarring. periodic&nbsp; optical device systems, like the 585-nm periodic&nbsp; dye optical device (PDL), afterward were developed and became the mainstays of medical care for each noninheritable&nbsp; and purchased tube lesions. These lasers provide glorious clinical improvement with an occasional risk of adverse sequelae. Transient blood disease is that the most typical adverse result of force unit treatment. Current technologic enhancements embrace dynamic surface cooling and extended pulse period, that enhance clinical results and minimize adverse effects.<br><br>CLASSIFICATION OF cutaneal tube LESIONS<br>Cutaneous tube lesions square measure categorised in keeping with mode and age of onset. noninheritable&nbsp; lesions begin in infancy and embrace port-wine stains, hemangiomas, blood vessel malformations, and lymphangiomas. noninheritable&nbsp; lesions square measure found most ordinarily on the top or neck and should be isolated or found as a part of a noninheritable&nbsp; syndrome like Sturge-Weber syndrome. nonheritable lesions develop in persons of any age and embrace telangiectasias, cherry angiomas, pathology granulomas, blood vessel lakes, poikiloderma, and Kaposi malignant neoplastic disease. nonheritable lesions could occur ad libitum, or they will be caused by trauma, ultraviolet exposure, or secretion changes.<br><br>Congenital lesions:<br><br>Port-wine stains<br><br>Port-wine stains, conjointly referred to as port-wine stain or capillary malformations, square measure gift at birth and occur equally in each sexes. The prevalence rate within the general population is zero.3-0.5%. Lesions tend to grow with the patient, while not a bent towards regression. they're typically set on the face, and therefore the V2 surgical instrument is affected most ordinarily. at the start showing as light-pink macules, port-wine stains will darken over time as a results of progressive vessel distension. superjacent soft tissue or bony hypertrophy could also be related to these lesions. Use of the force unit is that the most popular treatment thanks to its superior effectualness and low prevalence of adverse effects.<br><br>Hemangiomas<br><br>Hemangiomas square measure benign proliferations of blood vessels occurring in one0-12% of all kids by age 1 year. only 1 third of hemangiomas square measure gift at birth, and most square measure solitary lesions that occur on the top or neck. They usually bear a ascension part before involuting once AN undetermined quantity of your time. though some involution typically begins by the tip of the primary year, several hemangiomas don't utterly involute till the kid is aged 10-12 years.<br><br>Associated complications embrace ulceration, bleeding, infection, and scarring. ulcerous hemangiomas is terribly painful and frequently occur in association with chop-chop proliferating lesions. chop-chop proliferating hemangiomas of the face square measure notably regarding as a result of they will compromise very important structures or obscure vision. giant hemangiomas could also be related to Kasabach-Merritt syndrome, that incorporates a constellation of findings that has blood platelet destruction, anaemia, and coagulopathy. Hemangiomas are with success treated with lasers (ie, CW, PDL), excisional surgery, general corticosteroids, interferon, imiquimod, and surgical process.<br><br>Lymphangiomas<br><br>Lymphangiomas square measure slow-growing bodily fluid malformations that may be nonheritable once bodily fluid drain obstruction, chronic inflammation, infections, trauma, or surgical procedures. However, most square measure noninheritable&nbsp; and certain arise from a mix of abnormal budding of bodily fluid structures, failure of blood vessel vasculature to unite with the lymphatics, and atypical animal tissue sequestration throughout embryogenic development. Most of those lesions square measure diagnosed by age a pair of years, with nearly 0.5 diagnosed at birth.<br><br>Lymphangiomas square measure usually found as soft tissue plenty within the axillae or neck regions, however they'll occur in different locations like the tongue, esophagus, and higher airways. These lesions is classified as either superficial or deep. AN example of a superficial lesion is angioma circumscriptum, whereas the cystic hygroma may be a deep bodily fluid malformation usually found within the neck. Lymphangiomas is found in patients with sure body abnormalities like Turner syndrome.<br><br>If the patient is symptomless, a angioma could need no treatment; up to fifteen of cystic hygromas could ad libitum regress. Surgical excision is usually the popular treatment modality; but, thanks to the situation and potential involvement of significant structures, complete excision might not continuously be potential. different choices embrace sclerosing agents and optical device medical care. eminent treatment with lasers (ie, argon beam, Nd:YAG, PDL, carbon dioxide) has been according. they need been used for ablation, debulking, and complete excision. However, several lesions recur and treatment could need various sessions.<br><br>Acquired lesions<br><br>Telangiectasias<br><br>Telangiectasias square measure tiny, expanded vessels that square measure zero.1-1.5 metric linear unit in diameter. Telangiectasias unremarkably occur on the face and lower extremities and square measure as a result of a spread of causes. Facial telangiectasias will occur ad libitum, or they'll be caused by excessive ultraviolet exposure, collagen-vascular unwellness, acne, pregnancy, alcohol or steroid body process, or topical steroid application. kids ofttimes develop tiny facial telangiectasias that persist into adulthood. Lower extremity telangiectasias square measure additional common in ladies {and could|and should|and will} be genetic or may develop once maternity.<br><br>Treatment choices square measure various and embrace sclerotherapy, electrodesiccation, and intense pulsed-light or optical device medical care. Shorter optical device wavelengths are found to be more practical for treating redder, additional superficial vessels, however these parameters don't seem to be as eminent for deeper blue venulectasia and interconnected veins. The 1064-nm Nd:YAG optical device has been shown to with success improve lower extremity leg veins, particularly blue venulectasia and interconnected veins up to four metric linear unit in diameter. In one study, nearly 2 thirds of the patients achieved 75-100% clearing once only 1 optical device treatment; another study achieved important clearing in eightieth with up to three irradiations. Transient physiological state was the foremost common adverse result. Smaller leg telangiectasias could clear quicker and with less pain throughout treatment compared with larger vessels.<br><br>When sclerotherapy with zero.25% Na tetradecyl salt was compared with 1064-nm Nd:YAG optical device medical care for lower extremity telangiectasias (0.1-1.5 mm), important clinical improvement was seen all told sites with either modality. However, earlier clearing and better average improvement scores were seen with sclerotherapy. each modalities were related to pain and localized tissue erythroderma and lump. Temporary postinflammatory physiological state was seen solely with sclerotherapy.<br><br>Despite recent advances in optical device technology and therefore the effectiveness of lasers for facial telangiectasias, treatment of lower extremity telangiectasias with vascular-specific lasers is ineffective. Treatment failures square measure typically attributed to the larger size and deeper web site of lower extremity vessels and their association with deeper, feeding blood vessel plexuses. For these reasons, sclerotherapy is taken into account first-line treatment for many telangiectatic leg veins.<br><br>Cherry angiomas<br><br>Cherry angiomas square measure tiny, well-circumscribed, bright-red tube proliferations that originally seem in early adulthood and increase in variety with age. though benign, growths square measure simply treated with vascular-specific lasers to enhance cosmesis.<br><br>Pyogenic granulomas<br><br>A pathology tumour is AN nonheritable, benign, tube cutaneal growth that may conjointly have an effect on secretion membranes. These lesions square measure unremarkably found in infants and kids, accounting for about zero.5% of all skin nodules in kids. Clinically, pathology granulomas typically manifest as exhausting, red papules on the top and neck that square measure chop-chop enlarging; they regularly bleed or ulcerate. Treatment choices embrace surgical excision, shave excision with concomitant electrodesiccation to the bottom, thermocautery alone, PDLs, and copper optical device systems.<br><br>Poikiloderma<br><br>Poikiloderma of Civatte clinically seems as a cancellate, brown pigmentation of the neck, anterior chest, and lower face with distinguished telangiectasias caused by chronic sun exposure. Poikiloderma could also be with success treated with either the force unit or AN intense pulsed-light supply. the extreme pulsed-light supply could prove additional useful in eliminating associated physiological state thanks to its extra result on cuticular melanin; but, it's harder to use, notably in touchy areas like the neck and ches.<br><br><br>THE optical device SYSTEMS<br>Argon optical device<br><br>The CW argonon optical device was the primary optical device system wont to treat telangiectasias. It emits blue-green lightweight, and eightieth of its emission falls among the 488- to 514-nm portion of the spectrum. optical device energy is delivered during a continuous beam, with spot sizes starting from zero.1-1 mm, reaching tissue penetration depths of 1-2 metric linear unit. though argon's energy is preponderantly absorbed by hemoglobin, it's conjointly absorbed to a point by cuticular and dermal animal pigment thanks to its shorter wavelength. additionally, the laser's continuous mode of operation exceeds the thermal time constant of the tube target. Therefore, the argonon optical device is related to the next prevalence of operative pigmentary alteration and pathology, and it usually isn't thought-about helpful in darker-skinned people.<br><br>The {argon|Ar|atomic number one8|chemical element|element|noble gas|inert gas|argonon} laser's tiny spot size (up to 1 metric linear unit, compared with ten metric linear unit for the PDL) conjointly limits effective dermal penetration, more conducive to clinical ineffectuality. Despite the very fact that the argonon optical device is very operator-dependent and needs nice talent to by selection trace ectatic vessels while not destroying traditional tissue, it's the foremost eminent treatment certainly nonheritable tube lesions, together with telangiectasias, cherry angiomas, and angiokeratomas. However, the recognition of the argonon optical device has markedly declined over the past decade thanks to its associated limitations and therefore the development of the force unit.<br><br>Argon-pumped tunable dye optical device<br><br>The argon-pumped tunable dye optical device (APTDL) may be a quasi-CW mode optical device with high specificity for cutaneal tube structures. This optical device produces lightweight with wavelengths starting from 488-638 nm and might be operated within the yellow 577- to 585-nm vary for improved absorption by Hb. though the optical device is closed to deliver pulse periods as short as twenty milliseconds, most clinical applications need a minimum of a 100-millisecond period, that is way longer than the thermal time constant of telangiectatic vessels. Individual vessels square measure usually derived employing a 100-mm spot size and power settings of zero.1-0.4 W.<br><br>Adverse effects embrace symptom scarring, hypertrophic scarring, and permanent pigmentary alteration. the next prevalence of scarring is seen with the APTDL compared with the force unit thanks to the quasicontinuous nature of the previous system; but, as a result of the APTDL ends up in less operative blood disease and physiological state than the force unit, some patients could like the APTDL.<br><br>Potassium titanyl phosphate crystal optical device<br><br>The metal titanyl phosphate (KTP) optical device uses a 1064-nm Nd:YAG supply versed a KTP crystal to emit lightweight that's frequency-doubled with a wavelength of 532 nm. This quasi-CW optical device system uses time unit pulses to destroy tube targets. The KTP laser's 532-nm wavelength corresponds with the 542-nm absorption peak of hemoglobin, that makes it comparatively specific for cutaneal blood vessels. though the short wavelength doesn't leave deep tissue penetration, extended pulse periods up to fifty milliseconds improve its effectiveness. The KTP optical device is commonly wont to treat telangiectasias, and multiple treatments square measure necessary for larger-caliber vessels. almost like the quasi-CW argonon system, less blood disease, swelling, and pain square measure related to KTP optical device irradiation, however clinical results square measure systematically superior with the force unit.<br><br>Copper vapor and copper bromide lasers<br><br>Copper vapor and copper bromide lasers emit traffic light with a wavelength of 578 nm. These quasi-CW mode lasers deliver fast, 20-nanosecond pulses at a repetition rate of vi,000-15,000 pulses per second. Therefore, they're higher suited to the treatment of larger-caliber vessels with longer thermal relaxation times as a result of they need a bent to provide accrued thermal death in tissue. Facial telangiectasias, cherry angiomas, and pathology granulomas are eradicated with success with copper vapor and copper bromide systems. Absorption of energy by cuticular and dermal animal pigment conjointly happens, creating operative pigmentary alterations common. Thus, as a result of darker-skinned people square measure additional seemingly to expertise important postinflammatory pigmentary changes, the employment of either optical device ought to be restricted to patients with Fitzpatrick skin phototypes I-II. different posttreatment adverse effects embrace fine crusting and blistering that typically resolve over a 2-week amount.<br><br>Krypton optical device<br><br>The atomic number 36 optical device may be a quasi-CW mode optical device that emits inexperienced lightweight at 520-530 nm and traffic light at 568 nm. The 568-nm atomic number 36 optical device has been advocated for the treatment of facial telangiectasias. Vessels square measure derived employing a 1-mm handpiece with pulse period of zero.2 seconds and power settings starting from zero.5-0.75 W till the vessel disappears utterly. like different quasi-CW optical device systems, multiple treatment sessions at 3- to 4-week intervals square measure typically necessary. the foremost common adverse effects embrace erythroderma, edema, and gentle blistering or crusting.<br><br>Flashlamp-pumped force unit<br><br>Light energy emitted by the flashlamp-pumped force unit is primarily absorbed by hemoglobin contained among tube lumina, therefore minimizing thermal harm to different structures. The force unit was originally on the market at a wavelength of 577 nm, corresponding directly with the third absorption peak of hemoglobin, and a pulse period of 450 microseconds.<br><br>Over the past decade, the wavelength was extended to 585 nm and therefore the pulse period was accrued to one.5 milliseconds to result deeper tissue penetration while not compromising absorption by Hb. Also, a more recent 595-nm ultralong-PDL is adjusted for pulse durations from one.5-40 milliseconds. it's a cryogen-cooling device to decrease pain and adverse effects (eg, purpura). The longer-wavelength optical device will result even deeper penetration than the 585-nm optical device and should be favorable for treating sure telangiectasias. Typically, larger-caliber vessels need longer pulse durations to be effective, and therefore the 595-nm force unit is adjusted to correspond to the different-sized vessels being treated.<br><br>The force unit is taken into account the criterion commonplace treatment for port-wine stains, and it is wont to treat infants aged solely some weeks. The force unit is helpful within the treatment of superficial hemangiomas and during a style of nonheritable cutaneal tube lesions, together with telangiectasias, cherry angiomas, pathology granulomas, and poikiloderma of Civatte. pathology granulomas have conjointly been with success treated with the 585-nm force unit. However, some thicker lesions might not reply to medical care as a result of they're too deep. Some advocate multiple, overlapping pulses to treat these lesions; but, others compress the superficial vessels with a glass slide then administer the optical device. once the deeper portion has been treated, the slide is removed and therefore the superficial portion is treated. force unit treatment is very effective for reducing diffuse erythroderma and matted telangiectasias related to acne, property harm, and long steroid use.<br><br>Laser treatment parameters square measure supported many factors, together with lesion location, lesion morphology, and patient skin sort. Spot sizes starting from 2-10 metric linear unit square measure wont to deliver a fluence averaging 5-10 J/cm2. the employment of larger spot sizes and the next fluence permits deeper dermal penetration and destruction of larger-caliber vessels. Lower energy densities square measure necessary in ANatomic locations with an accrued risk of scarring, like the anterior chest, neck, and periorbital space. The Dr. ought to conjointly apply optical device pulses during a nonoverlapping manner to forestall excessive thermal harm that might end in organic process and pathology.<br><br>In general, expect port-wine stains to fade by eightieth once 8-10 treatments. Lesions on the face or neck tend to retort additional quickly than those on the lower extremities. Superficial and ulcerous hemangiomas conjointly respond favourably to the PDL; but, hemangiomas with a deeper element tend to be additional immune to optical device medical care, typically requiring concomitant corticosteroids. Port-wine stains treated with the force unit and a cryogen-cooling device are shown to own a considerably higher response at 585 nm than at 595 nm. Another study compared the results of employing a 595-nm force unit for port-wine stains that were refractory to treatment at 585 nm. No applied math advantage was found for mistreatment the longer wavelength for treatment. However, {it could|it's going to|it should} be advantageous to aim a check spot at 595 nm to see if any extra profit may occur with this wavelength.<br><br>The most common adverse effects embrace transient lump and blood disease, which can last up to 7-14 days. As a consequence, patients could like treatment with a 532-nm KTP optical device despite the superior effectualness of the force unit so as to eradicate telangiectasias with fewer treatments. though the employment of smaller spot sizes and lower energy densities reduces the degree of blood disease, these measures conjointly decrease clinical effectualness. different potential posttreatment adverse effects embrace transient physiological condition or physiological state, notably in dark-skinned or tanned people.<br><br>The use of a dynamic cooling device, that serves to cool down the stratum throughout optical device irradiation, permits safe application of the next fluence, even in patients with dark skin tones. The cooling device conjointly reduces the intensity and period of operative blood disease.<br><br>Intense periodic&nbsp; noncoherent lightweight<br><br>A noncoherent pulsed-light supply that emits morals the 500- to 1200-nm portion of the spectrum may be wont to treat a spread of cutaneal tube disorders. counting on lesion sort and size, cutoff filters of variable wavelengths (515 nm, 550 nm, 570 nm, 590 nm) square measure wont to eliminate shorter wavelengths. lightweight is delivered during a train of single, double, or triple pulses (2-25 milliseconds each) with variable time intervals between pulses (10-500 milliseconds). this method is very operator-dependent and permits treatment parameters (ie, wavelength, pulse duration, delays between pulses) to be tailored for every use.<br><br>The noncoherent pulsed-light supply has been wont to treat port-wine stains, hemangiomas, and facial or lower extremity telangiectasias. Smaller-caliber vessels respond best to treatment with lower cutoff filters (515 or 550 nm); larger-caliber vessels need longer-wavelength filters to result deeper tissue penetration. as a result of shorter-wavelength filters act additional promptly with cuticular and dermal animal pigment, these filters ought to be reserved for treating fair-skinned people (Fitzpatrick skin phototypes I-II). Smaller vessels square measure typically treated with single a pair of.5- to 5-millisecond pulses and a fluence starting from 25-45 J/cm2.<br><br><br>Higher energy densities (50-75 J/cm2) square measure used on larger vessels as a result of the energy is run as a train of pulses with long (40-60 milliseconds) delays between pulses. Higher energy densities allow adequate clotting whereas at the same time protective the superjacent stratum and periadnexal structures from excessive thermal harm. This mechanism of additive heating permits treatment of additional deeply placed vessels gift in hypertrophic port-wine stains or cavernous tube lesions. The 515-nm filter is employed for initial treatment, followed by the 550-nm filter to raised target larger, additional deeply placed telangiectasias. Adverse effects square measure gentle and embrace transient erythroderma and blood disease.<br><br>CONCLUSIONS<br>Congenital and purchased cutaneal tube lesions is treated effectively with a spread of quasi-CW and periodic&nbsp; lasers. though the quasi-CW mode lasers (ie, APTDL, KTP, copper vapor, krypton) will treat facial telangiectasias and different tube growths, the force unit has become the criterion commonplace of treatment thanks to its superior clinical effectualness and low complication rate. However, patients with darker skin sorts UN agency need treatment ought to be properly enlightened of the potential pigmentation changes and different adverse effects that may occur once force unit treatment.<br><br>Quasi-CW optical device systems is used for treating larger-caliber vessels, that need delivery of the next fluence. additionally, some patients like quasi-CW lasers thanks to the shrivelled incidence of operative blood disease. once force unit treatment, most patients expertise a point of erythroderma or blood disease, which might last 7-14 days. Despite these transient adverse effects, the force unit produces the foremost fast vessel clearance, with fewer overall treatments needed to eradicate lesions.<br><br>Laser medical care continues to advance within the treatment of unsought veins and telangiectasias. Shorter wavelengths are more practical for additional superficial, red telangiectasias; whereas, longer wavelengths are additional eminent for treating deeper blue venulectasia and interconnected veins up to four metric linear unit in diameter. as a result of lower extremity telangiectasias is immune to vascular-specific optical device irradiation, sclerotherapy is that the initial treatment of selection for many patients. a mix approach mistreatment sclerotherapy to treat the feeding interconnected veins and optical device irradiation to focus on the superficial telangiectasias could enhance vessel clearance. the extreme pulsed-light supply has conjointly been eminent within the treatment of lower leg veins. Patients with matted telangiectasias, distinguished veins below the mortise joint, or veins immune to sclerotherapy square measure ideal candidates for optical device treatment.<br><br><span style="font-weight: normal;" lang="fa"><p style="text-align: center;"><a title="لیزر حرارتی قوی" href="http://www.buy66.ir/thermal-laser/" rel="follow"><img class="alignnone wp-image-1010 size-full" title="لیزر حرارتی قوی" src="http://www.buy66.ir/wp-content/uploads/2014/10/524.jpg" alt="لیزر حرارتی قوی" height="320" width="580"></a></p></span>Importantly, bear in mind that patients ought to avoid surplus sun exposure before, during, and once optical device treatment as a result of sun exposure could decrease the effectualness of the procedure and should contribute to adverse events like operative pigmentation changes. As analysis within the field continues, lasers capable of removing ectatic tube growths, no matter size or location, with bottom risk and low morbidity can seemingly become on the market. more analysis is required to optimize these treatments.بر گرفته از emedicine -education -کتاب لیزر پوست و زیباییLaser treatment of cutaneal tube lesions has progressed considerably over the past twenty years. supported the pioneering work of Anderson and Maxfield Frederick Parrish within the early Eighties, many vascular-specific optical device systems are developed mistreatment principles of selective photothermolysis.Laser irradiation will by selection destroy specific targets (chromophores) among the skin by mistreatment AN acceptable wavelength and pulse period. Pulse period should be but or adequate to the targeted thermal time constant of the radical, ie, the time necessary for the target to cool down by half its peak temperature once optical device irradiation. as a result of the energy deposited within the tissue is proscribed to targeted sites, important thermal diffusion to adjacent skin is prevented. additionally, as a result of wavelengths like absorption peaks for numerous skin chromophores square measure famous, absorption of optical device energy is localized while not damaging neighboring structures. The targeted radical for tube lesions is intravascular oxyhemoglobin; therefore, thermal harm is basically restricted to cutaneal blood vessels.Early optical device technology used continuous-wave (CW) mode lasers for treating cutaneal tube lesions. These lasers failed to limit harm to the targeted tube structures, and, consequently, their use resulted during a high prevalence of scarring. periodic&nbsp; optical device systems, like the 585-nm periodic&nbsp; dye optical device (PDL), afterward were developed and became the mainstays of medical care for each noninheritable&nbsp; and purchased tube lesions. These lasers provide glorious clinical improvement with an occasional risk of adverse sequelae. Transient blood disease is that the most typical adverse result of force unit treatment. Current technologic enhancements embrace dynamic surface cooling and extended pulse period, that enhance clinical results and minimize adverse effects.CLASSIFICATION OF cutaneal tube LESIONSCutaneous tube lesions square measure categorised in keeping with mode and age of onset. noninheritable&nbsp; lesions begin in infancy and embrace port-wine stains, hemangiomas, blood vessel malformations, and lymphangiomas. noninheritable&nbsp; lesions square measure found most ordinarily on the top or neck and should be isolated or found as a part of a noninheritable&nbsp; syndrome like Sturge-Weber syndrome. nonheritable lesions develop in persons of any age and embrace telangiectasias, cherry angiomas, pathology granulomas, blood vessel lakes, poikiloderma, and Kaposi malignant neoplastic disease. nonheritable lesions could occur ad libitum, or they will be caused by trauma, ultraviolet exposure, or secretion changes.Congenital lesions:Port-wine stainsPort-wine stains, conjointly referred to as port-wine stain or capillary malformations, square measure gift at birth and occur equally in each sexes. The prevalence rate within the general population is zero.3-0.5%. Lesions tend to grow with the patient, while not a bent towards regression. they're typically set on the face, and therefore the V2 surgical instrument is affected most ordinarily. at the start showing as light-pink macules, port-wine stains will darken over time as a results of progressive vessel distension. superjacent soft tissue or bony hypertrophy could also be related to these lesions. Use of the force unit is that the most popular treatment thanks to its superior effectualness and low prevalence of adverse effects.HemangiomasHemangiomas square measure benign proliferations of blood vessels occurring in one0-12% of all kids by age 1 year. only 1 third of hemangiomas square measure gift at birth, and most square measure solitary lesions that occur on the top or neck. They usually bear a ascension part before involuting once AN undetermined quantity of your time. though some involution typically begins by the tip of the primary year, several hemangiomas don't utterly involute till the kid is aged 10-12 years.Associated complications embrace ulceration, bleeding, infection, and scarring. ulcerous hemangiomas is terribly painful and frequently occur in association with chop-chop proliferating lesions. chop-chop proliferating hemangiomas of the face square measure notably regarding as a result of they will compromise very important structures or obscure vision. giant hemangiomas could also be related to Kasabach-Merritt syndrome, that incorporates a constellation of findings that has blood platelet destruction, anaemia, and coagulopathy. Hemangiomas are with success treated with lasers (ie, CW, PDL), excisional surgery, general corticosteroids, interferon, imiquimod, and surgical process.LymphangiomasLymphangiomas square measure slow-growing bodily fluid malformations that may be nonheritable once bodily fluid drain obstruction, chronic inflammation, infections, trauma, or surgical procedures. However, most square measure noninheritable&nbsp; and certain arise from a mix of abnormal budding of bodily fluid structures, failure of blood vessel vasculature to unite with the lymphatics, and atypical animal tissue sequestration throughout embryogenic development. Most of those lesions square measure diagnosed by age a pair of years, with nearly 0.5 diagnosed at birth.Lymphangiomas square measure usually found as soft tissue plenty within the axillae or neck regions, however they'll occur in different locations like the tongue, esophagus, and higher airways. These lesions is classified as either superficial or deep. AN example of a superficial lesion is angioma circumscriptum, whereas the cystic hygroma may be a deep bodily fluid malformation usually found within the neck. Lymphangiomas is found in patients with sure body abnormalities like Turner syndrome.If the patient is symptomless, a angioma could need no treatment; up to fifteen of cystic hygromas could ad libitum regress. Surgical excision is usually the popular treatment modality; but, thanks to the situation and potential involvement of significant structures, complete excision might not continuously be potential. different choices embrace sclerosing agents and optical device medical care. eminent treatment with lasers (ie, argon beam, Nd:YAG, PDL, carbon dioxide) has been according. they need been used for ablation, debulking, and complete excision. However, several lesions recur and treatment could need various sessions.Acquired lesionsTelangiectasiasTelangiectasias square measure tiny, expanded vessels that square measure zero.1-1.5 metric linear unit in diameter. Telangiectasias unremarkably occur on the face and lower extremities and square measure as a result of a spread of causes. Facial telangiectasias will occur ad libitum, or they'll be caused by excessive ultraviolet exposure, collagen-vascular unwellness, acne, pregnancy, alcohol or steroid body process, or topical steroid application. kids ofttimes develop tiny facial telangiectasias that persist into adulthood. Lower extremity telangiectasias square measure additional common in ladies {and could|and should|and will} be genetic or may develop once maternity.Treatment choices square measure various and embrace sclerotherapy, electrodesiccation, and intense pulsed-light or optical device medical care. Shorter optical device wavelengths are found to be more practical for treating redder, additional superficial vessels, however these parameters don't seem to be as eminent for deeper blue venulectasia and interconnected veins. The 1064-nm Nd:YAG optical device has been shown to with success improve lower extremity leg veins, particularly blue venulectasia and interconnected veins up to four metric linear unit in diameter. In one study, nearly 2 thirds of the patients achieved 75-100% clearing once only 1 optical device treatment; another study achieved important clearing in eightieth with up to three irradiations. Transient physiological state was the foremost common adverse result. Smaller leg telangiectasias could clear quicker and with less pain throughout treatment compared with larger vessels.When sclerotherapy with zero.25% Na tetradecyl salt was compared with 1064-nm Nd:YAG optical device medical care for lower extremity telangiectasias (0.1-1.5 mm), important clinical improvement was seen all told sites with either modality. However, earlier clearing and better average improvement scores were seen with sclerotherapy. each modalities were related to pain and localized tissue erythroderma and lump. Temporary postinflammatory physiological state was seen solely with sclerotherapy.Despite recent advances in optical device technology and therefore the effectiveness of lasers for facial telangiectasias, treatment of lower extremity telangiectasias with vascular-specific lasers is ineffective. Treatment failures square measure typically attributed to the larger size and deeper web site of lower extremity vessels and their association with deeper, feeding blood vessel plexuses. For these reasons, sclerotherapy is taken into account first-line treatment for many telangiectatic leg veins.Cherry angiomasCherry angiomas square measure tiny, well-circumscribed, bright-red tube proliferations that originally seem in early adulthood and increase in variety with age. though benign, growths square measure simply treated with vascular-specific lasers to enhance cosmesis.Pyogenic granulomasA pathology tumour is AN nonheritable, benign, tube cutaneal growth that may conjointly have an effect on secretion membranes. These lesions square measure unremarkably found in infants and kids, accounting for about zero.5% of all skin nodules in kids. Clinically, pathology granulomas typically manifest as exhausting, red papules on the top and neck that square measure chop-chop enlarging; they regularly bleed or ulcerate. Treatment choices embrace surgical excision, shave excision with concomitant electrodesiccation to the bottom, thermocautery alone, PDLs, and copper optical device systems.PoikilodermaPoikiloderma of Civatte clinically seems as a cancellate, brown pigmentation of the neck, anterior chest, and lower face with distinguished telangiectasias caused by chronic sun exposure. Poikiloderma could also be with success treated with either the force unit or AN intense pulsed-light supply. the extreme pulsed-light supply could prove additional useful in eliminating associated physiological state thanks to its extra result on cuticular melanin; but, it's harder to use, notably in touchy areas like the neck and ches.THE optical device SYSTEMSArgon optical deviceThe CW argonon optical device was the primary optical device system wont to treat telangiectasias. It emits blue-green lightweight, and eightieth of its emission falls among the 488- to 514-nm portion of the spectrum. optical device energy is delivered during a continuous beam, with spot sizes starting from zero.1-1 mm, reaching tissue penetration depths of 1-2 metric linear unit. though argon's energy is preponderantly absorbed by hemoglobin, it's conjointly absorbed to a point by cuticular and dermal animal pigment thanks to its shorter wavelength. additionally, the laser's continuous mode of operation exceeds the thermal time constant of the tube target. Therefore, the argonon optical device is related to the next prevalence of operative pigmentary alteration and pathology, and it usually isn't thought-about helpful in darker-skinned people.The {argon|Ar|atomic number one8|chemical element|element|noble gas|inert gas|argonon} laser's tiny spot size (<span style="font-weight: normal;" lang="fa"><a title=" لیزر حرارتی اصل" href="http://www.buy66.ir/thermal-laser/" rel="follow"><strong> لیزر حرارتی اصل</strong></a></span>) conjointly limits effective dermal penetration, more conducive to clinical ineffectuality. Despite the very fact that the argonon optical device is very operator-dependent and needs nice talent to by selection trace ectatic vessels while not destroying traditional tissue, it's the foremost eminent treatment certainly nonheritable tube lesions, together with telangiectasias, cherry angiomas, and angiokeratomas. However, the recognition of the argonon optical device has markedly declined over the past decade thanks to its associated limitations and therefore the development of the force unit.Argon-pumped tunable dye optical deviceThe argon-pumped tunable dye optical device (APTDL) may be a quasi-CW mode optical device with high specificity for cutaneal tube structures. This optical device produces lightweight with wavelengths starting from 488-638 nm and might be operated within the yellow 577- to 585-nm vary for improved absorption by Hb. though the optical device is closed to deliver pulse durations as short as twenty milliseconds, most clinical applications need a minimum of a 100-millisecond period, that is way longer than the thermal time constant of telangiectatic vessels. Individual vessels square measure usually derived employing a 100-mm spot size and power settings of zero.1-0.4 W.Adverse effects embrace symptom scarring, hypertrophic scarring, and permanent pigmentary alteration. the next prevalence of scarring is seen with the APTDL compared with the force unit thanks to the quasicontinuous nature of the previous system; but, as a result of the APTDL ends up in less operative blood disease and physiological state than the force unit, some patients could like the APTDL.Potassium titanyl phosphate crystal optical deviceThe metal titanyl phosphate (KTP) optical device uses a 1064-nm Nd:YAG supply versed a KTP crystal to emit lightweight that's frequency-doubled with a wavelength of 532 nm. This quasi-CW optical device system uses time unit pulses to destroy tube targets. The KTP laser's 532-nm wavelength corresponds with the 542-nm absorption peak of hemoglobin, that makes it comparatively specific for cutaneal blood vessels. though the short wavelength doesn't leave deep tissue penetration, extended pulse durations up to fifty milliseconds improve its effectiveness. The KTP optical device is commonly wont to treat telangiectasias, and multiple treatments square measure necessary for larger-caliber vessels. almost like the quasi-CW argonon system, less blood disease, swelling, and pain square measure related to KTP optical device irradiation, however clinical results square measure systematically superior with the force unit.Copper vapor and copper bromide lasersCopper vapor and copper bromide lasers emit traffic light with a wavelength of 578 nm. These quasi-CW mode lasers deliver fast, 20-nanosecond pulses at a repetition rate of vi,000-15,000 pulses per second. Therefore, they're higher suited to the treatment of larger-caliber vessels with longer thermal relaxation times as a result of they need a bent to provide accrued thermal death in tissue. Facial telangiectasias, cherry angiomas, and pathology granulomas are eradicated with success with copper vapor and copper bromide systems. Absorption of energy by cuticular and dermal animal pigment conjointly happens, creating operative pigmentary alterations common. Thus, as a result of darker-skinned people square measure additional seemingly to expertise important postinflammatory pigmentary changes, the employment of either optical device ought to be restricted to patients with Fitzpatrick skin phototypes I-II. different posttreatment adverse effects embrace fine crusting and blistering that typically resolve over a 2-week amount.Krypton optical deviceThe atomic number 36 optical device may be a quasi-CW mode optical device that emits inexperienced lightweight at 520-530 nm and traffic light at 568 nm. The 568-nm atomic number 36 optical device has been advocated for the treatment of facial telangiectasias. Vessels square measure derived employing a 1-mm handpiece with pulse period of zero.2 seconds and power settings starting from zero.5-0.75 W till the vessel disappears utterly. like different quasi-CW optical device systems, multiple treatment sessions at 3- to 4-week intervals square measure typically necessary. the foremost common adverse effects embrace erythroderma, edema, and gentle blistering or crusting.Flashlamp-pumped force unitLight energy emitted by the flashlamp-pumped force unit is primarily absorbed by hemoglobin contained among tube lumina, therefore minimizing thermal harm to different structures. The force unit was originally on the market at a wavelength of 577 nm, corresponding directly with the third absorption peak of hemoglobin, and a pulse period of 450 microseconds.Over the past decade, the wavelength was extended to 585 nm and therefore the pulse period was accrued to one.5 milliseconds to result deeper tissue penetration while not compromising absorption by Hb. Also, a more recent 595-nm ultralong-PDL is adjusted for pulse durations from one.5-40 milliseconds. it's a cryogen-cooling device to decrease pain and adverse effects (eg, purpura). The longer-wavelength optical device will result even deeper penetration than the 585-nm optical device and should be favorable for treating sure telangiectasias. Typically, larger-caliber vessels need longer pulse durations to be effective, and therefore the 595-nm force unit is adjusted to correspond to the different-sized vessels being treated.The force unit is taken into account the criterion commonplace treatment for port-wine stains, and it is wont to treat infants aged solely some weeks. The force unit is helpful within the treatment of superficial hemangiomas and during a style of nonheritable cutaneal tube lesions, together with telangiectasias, cherry angiomas, pathology granulomas, and poikiloderma of Civatte. pathology granulomas have conjointly been with success treated with the 585-nm force unit. However, some thicker lesions might not reply to medical care as a result of they're too deep. Some advocate multiple, overlapping pulses to treat these lesions; but, others compress the superficial vessels with a glass slide then administer the optical device. once the deeper portion has been treated, the slide is removed and therefore the superficial portion is treated. force unit treatment is very effective for reducing diffuse erythroderma and matted telangiectasias related to acne, property harm, and long steroid use.Laser treatment parameters square measure supported many factors, together with lesion location, lesion morphology, and patient skin sort. Spot sizes starting from 2-10 metric linear unit square measure wont to deliver a fluence averaging 5-10 J/cm2. the employment of larger spot sizes and the next fluence permits deeper dermal penetration and destruction of larger-caliber vessels. Lower energy densities square measure necessary in ANatomic locations with an accrued risk of scarring, like the anterior chest, neck, and periorbital space. The Dr. ought to conjointly apply optical device pulses during a nonoverlapping manner to forestall excessive thermal harm that might end in organic process and pathology.In general, expect port-wine stains to fade by eightieth once 8-10 treatments. Lesions on the face or neck tend to retort additional quickly than those on the lower extremities. Superficial and ulcerous hemangiomas conjointly respond favourably to the PDL; but, hemangiomas with a deeper element tend to be additional immune to optical device medical care, typically requiring concomitant corticosteroids. Port-wine stains treated with the force unit and a cryogen-cooling device are shown to own a considerably higher response at 585 nm than at 595 nm. Another study compared the results of employing a 595-nm force unit for port-wine stains that were refractory to treatment at 585 nm. No applied math advantage was found for mistreatment the longer wavelength for treatment. However, {it could|it's going to|it should} be advantageous to aim a check spot at 595 nm to see if any extra profit may occur with this wavelength.The most common adverse effects embrace transient lump and blood disease, which can last up to 7-14 days. As a consequence, patients could like treatment with a 532-nm KTP optical device despite the superior effectualness of the force unit so as to eradicate telangiectasias with fewer treatments. though the employment of smaller spot sizes and lower energy densities reduces the degree of blood disease, these measures conjointly decrease clinical effectualness. different potential posttreatment adverse effects embrace transient physiological condition or physiological state, notably in dark-skinned or tanned people.The use of a dynamic cooling device, that serves to cool down the stratum throughout optical device irradiation, permits safe application of the next fluence, even in patients with dark skin tones. The cooling device conjointly reduces the intensity and period of operative blood disease.Intense periodic&nbsp; noncoherent lightweightA noncoherent pulsed-light supply that emits morals the 500- to 1200-nm portion of the spectrum may be wont to treat a spread of cutaneal tube disorders. counting on lesion sort and size, cutoff filters of variable wavelengths (515 nm, 550 nm, 570 nm, 590 nm) square measure wont to eliminate shorter wavelengths. lightweight is delivered during a train of single, double, or triple pulses (2-25 milliseconds each) with variable time intervals between pulses (10-500 milliseconds). this method is very operator-dependent and permits treatment parameters (ie, wavelength, pulse duration, delays between pulses) to be tailored for every use.The noncoherent pulsed-light supply has been wont to treat port-wine stains, hemangiomas, and facial or lower extremity telangiectasias. Smaller-caliber vessels respond best to treatment with lower cutoff filters (515 or 550 nm); larger-caliber vessels need longer-wavelength filters to result deeper tissue penetration. as a result of shorter-wavelength filters act additional promptly with cuticular and dermal animal pigment, these filters ought to be reserved for treating fair-skinned people (Fitzpatrick skin phototypes I-II). Smaller vessels square measure typically treated with single a pair of.5- to 5-millisecond pulses and a fluence starting from 25-45 J/cm2.Higher energy densities (50-75 J/cm2) square measure used on larger vessels as a result of the energy is run as a train of pulses with long (40-60 milliseconds) delays between pulses. Higher energy densities allow adequate clotting whereas at the same time protective the superjacent stratum and periadnexal structures from excessive thermal harm. This mechanism of additive heating permits treatment of additional deeply placed vessels gift in hypertrophic port-wine stains or cavernous tube lesions. The 515-nm filter is employed for initial treatment, followed by the 550-nm filter to raised target larger, additional deeply placed telangiectasias. Adverse effects square measure gentle and embrace transient erythroderma and blood disease.CONCLUSIONSCongenital and purchased cutaneal tube lesions is treated effectively with a spread of quasi-CW and periodic&nbsp; lasers. though the quasi-CW mode lasers (ie, APTDL, KTP, copper vapor, krypton) will treat facial telangiectasias and different tube growths, the force unit has become the criterion commonplace of treatment thanks to its superior clinical effectualness and low complication rate. However, patients with darker skin sorts UN agency need treatment ought to be properly enlightened of the potential pigmentation changes and different adverse effects that may occur once force unit treatment.Quasi-CW optical device systems is used for treating larger-caliber vessels, that need delivery of the next fluence. additionally, some patients like quasi-CW lasers thanks to the shrivelled incidence of operative blood disease. once force unit treatment, most patients expertise a point of erythroderma or blood disease, which might last 7-14 days. Despite these transient adverse effects, the force unit produces the foremost fast vessel clearance, with fewer overall treatments needed to eradicate lesions.Laser medical care continues to advance within the treatment of unsought veins and telangiectasias. Shorter wavelengths are more practical for additional superficial, red telangiectasias; whereas, longer wavelengths are additional eminent for treating deeper blue venulectasia and interconnected veins up to four metric linear unit in diameter. as a result of lower extremity telangiectasias is immune to vascular-specific optical device irradiation, sclerotherapy is that the initial treatment of selection for many patients. a mix approach mistreatment sclerotherapy to treat the feeding interconnected veins and optical device irradiation to focus on the superficial telangiectasias could enhance vessel clearance. the extreme pulsed-light supply has conjointly been eminent within the treatment of lower leg veins. Patients with matted telangiectasias, distinguished veins below the mortise joint, or veins immune to sclerotherapy square measure ideal candidates for optical device treatment.Importantly, bear in mind that patients ought to avoid surplus sun exposure before, during, and once optical device treatment as a result of sun exposure could decrease the effectualness of the procedure and should contribute to adverse events like operative pigmentation changes. As analysis within the field continues, lasers capable of removing ectatic tube growths, no matter size or location, with bottom risk and low morbidity can seemingly become on the market. more analysis is required to optimize these treatments.</div><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>





<br><br></p>
        </div>
                
                <br>

        <div class="comment clearfix">
            <a style="float:left;margin-left:15px;margin-top: 5px;"  target="_blank"
               href="http://www.cloob.com/share/link/add?
								url=http://sookootshab.mihanblog.com//post/3&title= لیزر حرارتی اصل">
                <img alt="داغ کن - کلوب دات کام" src="http://cloob.com/public/public/images/icon/100c.gif" style='border: none; padding: 0px'/>
            </a>
            <div class="PostCom" style="padding-bottom: 12px;"><a style="float: right;" target="_self" href="3.html#commentlist" class="comment-link">نظرات(<script>setCommentCnt(3)</script>)</a>&nbsp;

                <div style="float: right;margin-right: 5px;margin-top:-3px;"><script>mihanblogPostLike('3','like')</script></div>


            </div>

        </div>
    </div>




<!-- comment -->
<div>


    <style>

            /*** COMMENT BODY***/
        .comment_body{
            background: #dfeaf8;
            margin:10px;
            border-radius: 5px;
            border-right:5px solid #c5d8ee;
            overflow:hidden;

        }

        .comment .comment_reply {
            background: #8199b5;
            border-right: 5px solid #516d8e;
            border-radius: 5px;
            width: 350px;
            font-size: 12px;
            color:#fff;
            font-size:12px;
            overflow:hidden;
        }



        .comment .name {
            font-weight: 600;
            color: #4E3E09;
            padding-right: 5px;
            text-align: right;
            line-height: 26px;
            float: right;
        }


        .comment .date {
            font-size: 10px;
            padding: 5px;
            color: #7E7E7E;
            float: left;
        }


        .comment .comemnt_web {
            padding: 5px 0 5px 15px; color: #999; direction: ltr; text-align: left;

        }


        .comment .comemnt_web a {
            color: #554c3d;
            text-decoration: underline;
        }


        .comment_det{
            border-bottom:1px solid #D8E9FE;
            padding:4px;

        }

        .comment .comemnt_text {
            text-align: justify;
            line-height: 1.5em;
            padding: 2px 5px;
            text-align: right;
            direction: rtl;
        }

        .comment .name,.date,.comemnt_text,.comment_reply{
            margin-right:3px;
            padding-right:3px;

        }

            /**** COMMENT FORM ****/

        .comment_form {
            background: none repeat scroll 0 0 #adc3dd;
            border-radius: 5px 5px 5px 5px;
            border-right: 5px solid #97b3d5;
            direction: rtl;
            margin: 10px;
            padding: 20px;
        }



        .comment_form label {
            width: 100px;
            display: block;
            float: right;
            text-align: left;
            font-size: 10px;
            color: #555;
            padding-left: 10px;
        }


        .comment_form .comment_form_row {
            margin: 3px 0;
        }


        #imageCodeWrapper .imageCode_input #imgstr {
            font-size: 25px;
            height: 34px;
            width: 70px;
        }

        .comment_form_textbox {
            width:240px;

        }
        .comment_form_textarea{
            width:240px;
        }

        .comment_form .comment_form_textarea, .comment_form .comment_form_textbox {
            border: 1px solid #C5C5C5;
        }




    </style>

            <div class="cb_general">
            <a name='commentlist'></a>            <div class="comment_form_body">
                <style>


#imageCodeWrapper div{
	float: right;
}
#imageCodeWrapper .imageCode_input #imgstr{
	width:83px;
	height:34px;
	font-size:25px;
}
#imageCodeWrapper .imageCode_number{
	margin:1px 5px 0px 0px;
}
#imageCodeWrapper .imageCode_number img{
 	border: 0px;
 	width: 122px;
 	height: 37px;
}
#imageCodeWrapper .imageCode_refresh{
	cursor:pointer;
	margin: 3px 3px 0px 0px;

	width: 16px;
	height: 16px;

    background:url(http://static.mihanblog.com//public/images/icon/gen/refresh.gif) center right no-repeat;
}

.clearfix {display: inline-block;}
.clearfix:after {
    content: ".";
    display: block;
    height: 0;
    clear: both;
    visibility: hidden;
}
* html .clearfix {height: 1%;}
.clearfix {display: block;}



.comment_form .err-msg{
	padding-right: 110px;
	color: #F00;
}
.comment_form{
	direction: rtl;
}

.comment_form label{
	width: 110px;
	display: block;
	float: right;
}
.comment_form .comment_form_msg{
	background: none repeat scroll 0 0 #8CDA5C;
    border: 1px solid #249224;
    padding: 5px;
    margin: 5px;
}
.comment_form .required{
	background: url(http://static.mihanblog.com//public/images/icon/require2.gif) no-repeat right top;
	padding-right: 20px;
}

.comment_form .required{
	width: 90px;
}
.comment_form .controls{
	text-align: center;
}
.comment_form .btn{
	font-family: tahoma;
}
.smileLayer{
    position:absolute;
    display:none;
    background-color:#fff;
    border:1px solid #555;
}
    .msgbody{
        float:right;
        width:260px
    }
    .msgtitle{
        float:right;
        -width:57px;
        text-align:right;
        -padding-right:64px;
    }
</style>

<script>
    var mihanBlog_commentBody_cursorPos=0;
    function set_mihanBlogCommentBodyCursorPos(textarea_id){
        mihanBlog_commentBody_cursorPos = c_$(textarea_id).selectionStart;
    }
</script>

<form id="frm-16082178735fdb7511cef42" method="post" action="http://sookootshab.mihanblog.com/post/comment/new/3/fromtype/postone/fid/16082178735fdb7511cef42/atrty/1608217873/avrvy/0/key/5f3339cb7799270b5ab01b9766aa7007/#post_form" >
	<a name="post_form"></a>
	<div class="comment_form">

					<div class="comment_form_row clearfix">
				<label for="full_name">نام (فارسی):</label>
				<input type="text" name="data[full_name]" id="full_name" value="" class="comment_form_textbox" />			</div>

			<div class="comment_form_row clearfix">
				<label for="email">ایمیل :</label>
				<input type="text" name="data[email]" id="email" value="" class="comment_form_textbox english" />			</div>

			<!--
            <div class="comment_form_row clearfix">
				<label for="web">آدرس وب/وبلاگ :</label>
				<input type="text" name="data[web]" id="web" value="" class="comment_form_textbox english" />			</div>
            -->

			<div class="comment_form_row clearfix">
				<label for="remember">مرا بخاطر بسپار :</label>
				<input type="checkbox"  name="data[remember]" id="remember" value="1" />			</div>

			<div class="comment_form_row clearfix">

                <div class="msgtitle" for="title">
                	<label class="required">
                    	متن نظر (فارسی): 					</label>
                     <!--   
                    <div id="showsmile" style="position: relative;">
                        <img src="http://static.mihanblog.com//public/rte/images_new/smiley.gif" onClick="showMihanBlogSmileBox('body')" style="cursor:pointer" />                    </div>
                    <div class="smileLayer" id="MihanBlogSmiles_body"><table cellpadding="0"  cellspacing="0"  width="120"><tr><td colspan=2>&nbsp;</td><td style="cursor:pointer;text-align:left;padding:3px 0px 0px 3px;" onclick="showMihanBlogSmileBox('body')"><img src="http://static.mihanblog.com//public/images/icon/close.gif"  /></td></tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/1.gif" onClick="MihanBlogShowSmile('لبخند','body')" title="لبخند" alt="لبخند" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/2.gif" onClick="MihanBlogShowSmile('ناراحت','body')" title="ناراحت" alt="ناراحت" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/3.gif" onClick="MihanBlogShowSmile('چشمک','body')" title="چشمک" alt="چشمک" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/4.gif" onClick="MihanBlogShowSmile('نیشخند','body')" title="نیشخند" alt="نیشخند" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/6.gif" onClick="MihanBlogShowSmile('بغل','body')" title="بغل" alt="بغل" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/7.gif" onClick="MihanBlogShowSmile('سوال','body')" title="سوال" alt="سوال" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/8.gif" onClick="MihanBlogShowSmile('قلب','body')" title="قلب" alt="قلب" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/9.gif" onClick="MihanBlogShowSmile('خجالت','body')" title="خجالت" alt="خجالت" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/10.gif" onClick="MihanBlogShowSmile('زبان','body')" title="زبان" alt="زبان" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/11.gif" onClick="MihanBlogShowSmile('ماچ','body')" title="ماچ" alt="ماچ" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/13.gif" onClick="MihanBlogShowSmile('تعجب','body')" title="تعجب" alt="تعجب" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/14.gif" onClick="MihanBlogShowSmile('عصبانی','body')" title="عصبانی" alt="عصبانی" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/16.gif" onClick="MihanBlogShowSmile('عینک','body')" title="عینک" alt="عینک" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/19.gif" onClick="MihanBlogShowSmile('شیطان','body')" title="شیطان" alt="شیطان" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/20.gif" onClick="MihanBlogShowSmile('گریه','body')" title="گریه" alt="گریه" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/21.gif" onClick="MihanBlogShowSmile('خنده','body')" title="خنده" alt="خنده" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/24.gif" onClick="MihanBlogShowSmile('قهقهه','body')" title="قهقهه" alt="قهقهه" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/27.gif" onClick="MihanBlogShowSmile('خداحافظ','body')" title="خداحافظ" alt="خداحافظ" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/31.gif" onClick="MihanBlogShowSmile('سبز','body')" title="سبز" alt="سبز" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/33.gif" onClick="MihanBlogShowSmile('قهر','body')" title="قهر" alt="قهر" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/36.gif" onClick="MihanBlogShowSmile('هورا','body')" title="هورا" alt="هورا" style="cursor:pointer" /></td>	</tr>	<tr><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/41.gif" onClick="MihanBlogShowSmile('دست','body')" title="دست" alt="دست" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/53.gif" onClick="MihanBlogShowSmile('گل','body')" title="گل" alt="گل" style="cursor:pointer" /></td><td width="40px" height="30px" align="center"><img src="http://static.mihanblog.com//public/rte/images_new/smiles/39.gif" onClick="MihanBlogShowSmile('تفکر','body')" title="تفکر" alt="تفکر" style="cursor:pointer" /></td>	</tr>	</table></div>                    -->
                </div>
                
                <div class="msgbody">
				    <textarea name="data[body]" id="body" class="comment_form_textarea" onkeyup="showCaptcha();set_mihanBlogCommentBodyCursorPos('body');" onkeypress="set_mihanBlogCommentBodyCursorPos('body');" onclick="set_mihanBlogCommentBodyCursorPos('body');" rows="8" cols="40"></textarea>                </div>

                <script type="text/javascript">

                                        var showCaptcha = function(){
                                                    if(c_$('body').value.length>5){
                                c_$("imageCodeWrapper").style.display="";
                            }
                                            }
                </script>
			</div>

			<div class="comment_form_row clearfix">
				<label for="private">ارسال نظر خصوصی :</label>
				<input type="checkbox"  name="data[private]" id="private" value="1" />			</div>
        
							<div class="comment_form_row clearfix">
					نظرات پس از تایید نشان داده خواهند شد.				</div>
			
			<div class="controls clearfix">
				
        		<style>
        		    #imgstr{
        		        font-size:12px;
        		    }
        		</style>
        		<div id="imageCodeWrapper" class="comment_form_row clearfix">
	        			<label class="required" for="imgstr">عبارت تصویر :</label>
	        			
	        			<div class="imageCode_input">
	        				<input type="text" name="imgstr" id="imgstr" style="" class="comment_form_textbox">
	        			</div>
		        		<div class="imageCode_number">
	        				<img id="imgcodepage_440821" style="width: auto; height: auto;max-width:140px" src="http://sookootshab.mihanblog.com/public/public/html/imgcode.php?str=f95ce93ddc1a6eba956b1e7ea0862810____ibeevvvbep35" >
	        			</div>
	        			<div class="imageCode_refresh" title="تعویض عبارت تصویری" onclick="changeImgCode_440821();"></div>	
	        	</div>
	        	<input type="hidden" name="imgcode" id="imgcode_440821" value="f95ce93ddc1a6eba956b1e7ea0862810____ibeevvvbep35">
        		<script>
        		var imgCodeChangeNum_440821 = 0 ;
        		changeImgCode_440821 = function (){
	        		var ImgCodeArr_440821 = new Array();
	        		ImgCodeArr_440821[1]="484d33c243499025ea5aee45257b30c6____akqzqorzzs43";
	        		ImgCodeArr_440821[2]="5bdc86121b82bf52c3b17c4b1cde12fc____eqbddnydq59";
	        		ImgCodeArr_440821[3]="3c7e7f21336e2bdb283199744174a975____mmfeyohbo59";
	        		ImgCodeArr_440821[4]="a2c08b67525e9255fb2c887d68491828____cyyfsbvvr75";
	        		
	        		
	        		if(imgCodeChangeNum_440821<4){
	        			imgCodeChangeNum_440821 ++ ;
	        		}
	        		else{
	        			imgCodeChangeNum_440821 = 1 ;
	        		}
	        		
	        		c_$("imgcode_440821").value = ImgCodeArr_440821[imgCodeChangeNum_440821];
	        		document.getElementById("imgcodepage_440821").src = "/public/public/html/imgcode.php?str="+ImgCodeArr_440821[imgCodeChangeNum_440821];
        		}
        		</script>
        		<input type="submit" value="ارسال" class="btn" classRow="comment_form_row" onclick="click_send()" />
			</div>
	</div>

<input type="hidden" name="frm-id" value="16082178735fdb7511cef42" id="frm-id" /></form>
<script>
function click_send(){

	Delete_Cookie( 'CMDinfo','/post/', '.mihanblog.com' );

	if(c_$('remember').checked){
		var cookieStr = c_$('full_name').value +"_____"+c_$('email').value+"_____"+c_$('web').value;
		Set_Cookie( 'CMDinfo', cookieStr , 1, '/post/', '.mihanblog.com', 0 );
	}
}


//LOAD
var CMDinfo = Get_Cookie('CMDinfo');

if(CMDinfo)
{
	CMDinfo = CMDinfo.split("_____");
	c_$('full_name').value = CMDinfo[0];
	c_$('email').value = CMDinfo[1];
	c_$('web').value = CMDinfo[2];
	c_$('remember').checked = true;
}

</script>            </div>
        </div>
    </div>

<!-- End comment -->


<br>
<br>
<div align="center" class="page_box clearfix">
    </div>
</div>

<div class="right-top">
    <div class="rss">
        <a href="rss/index.html">RSS </a>
    </div>
    <div class="search">
        <form id="frm-16082178735fdb7511cf480" method="get" action="http://sookootshab.mihanblog.com/post/search/fid/16082178735fdb7511cf480"  onsubmit="window.open('', 'search', 'toolbar=0,location=0,status=0,menubar=0,scrollbars=1,resizable=0,width=400,height=310')" target="search"> 
            <input type="text"  name="search_text" value="جستجو" class="text" onclick="this.value=''">
            <input type="submit"  value="جستجو" class="submit">
        <input type="hidden" name="frm-id" value="16082178735fdb7511cf480" id="frm-id" /></form>    </div>
</div>
<div class="right">
    <div class="nav">
        <h2><div>درباره وبلاگ</div></h2>
        <div style="text-align:center; margin-bottom:10px;"></div>
        <div style="text-align:justify; direction:rtl;">گیره کوچک کننده بینی,گیره کوچک کننده بینی خوبه,گیره کوچک کننده بینی نوز آپ,گیره کوچک کننده بینی گوشتی,گیره کوچک کننده بینی خرید,خرید گیره کوچک کننده بینی</div>
    </div>
            <div class="nav">
            <div class="archive">
                <h2><div>آرشیو</div></h2>
                                    <a href="archive/1397/6.html"> شهریور 1397</a>
                                    <a href="archive/1397/3.html"> خرداد 1397</a>
                                    <a href="archive/1397/2.html"> اردیبهشت 1397</a>
                                    <a href="archive/1397/1.html"> فروردین 1397</a>
                                    <a href="archive/1396/12.html"> اسفند 1396</a>
                                    <a href="archive/1396/11.html"> بهمن 1396</a>
                                    <a href="archive/1396/10.html"> دی 1396</a>
                                    <a href="archive/1396/7.html"> مهر 1396</a>
                                    <a href="archive/1396/6.html"> شهریور 1396</a>
                                    <a href="archive/1396/3.html"> خرداد 1396</a>
                                    <a href="archive/1396/2.html"> اردیبهشت 1396</a>
                                    <a href="archive/1396/1.html"> فروردین 1396</a>
                
                <a href="archive.html"><b>لیست آرشیوها</b></a></li>
            </div>
        </div>
    

            <div class="nav">
            <h2><div>آخرین پستها</div></h2>
                            <a  href="449.html">گلچین زیباترین شعر در مورد تشکر </a>
                            <a  href="448.html">علائم و درمان و نشانه های درد کیسه صفرا چیست </a>
                            <a  href="447.html">علل تیرگی دور چشم و درمان آن </a>
                            <a  href="446.html"> علل درد مچ پا </a>
                            <a  href="445.html">خروسک </a>
                            <a  href="444.html">شعر در مورد تلاوت قرآن </a>
                            <a  href="443.html">جوز هندی </a>
                            <a  href="442.html">خواص انگور در بارداری و حاملگی </a>
                            <a  href="441.html">خاکشیر و لاغری </a>
                            <a  href="440.html">خواص میخک در طب سنتی از نظر بزرگان </a>
                            <a  href="439.html">زالزالک و فشار خون </a>
                            <a  href="438.html">خرما و فشار خون </a>
                            <a  href="437.html">طریقه مصرف و خواص جوانه گندم برای چاقی صورت و درمان جوش صورت </a>
                            <a  href="436.html">معجون سیاه دانه و عسل در طب سنتی </a>
                            <a  href="435.html">شعر در مورد بیماری </a>
                        <b><a  href="list.html">لیست آخرین پستها</a></b>
        </div>
    
            <div class="nav">
            <h2><div>پیوندها</div></h2>
                            <a href="http://smallnosesmall.blog.ir/" title=""  target="_blank">خرید گیره کوچک کننده بینی نوز آپ</a>
                            <a href="http://smallnosesmall.loxblog.com/" title=""  target="_blank">گیره کوچک کننده بینی نوز آپ اصل</a>
                            <a href="http://smallnosesmall.blogsky.com/" title=""  target="_blank">گیره کوچک کننده بینی نوزآپ</a>
                        <a href="../link/index.html"><b>همه پیوندها</b></a>
        </div>
    

    

    


    

            <div class="nav">
            <h2><div>نویسندگان</div></h2>
                            <p><a href="author/1190609.html"></a><a class="clearfix" href="author/1190609.html" >	مسعود هاشمی(440)</a>	</p>
                    </div>
    


            <div class="nav">
            <h2><div>ابر برچسبها</div></h2>
                            <a href="tag/درد+کیسه+صفرا+چگونه+است.html" style="font-size:1em">	درد کیسه صفرا چگونه است</a>
                            <a href="tag/اس+ام+اس+باران.html" style="font-size:2em">	اس ام اس باران</a>
                            <a href="tag/درد+کیسه+صفراء.html" style="font-size:1em">	درد کیسه صفراء</a>
                            <a href="tag/درد+کیسه+صفرا.html" style="font-size:1em">	درد کیسه صفرا</a>
                            <a href="tag/درد+کیسه+صفرا+در+بارداری.html" style="font-size:1em">	درد کیسه صفرا در بارداری</a>
                            <a href="tag/درد+کیسه+صفرا+درمان.html" style="font-size:1em">	درد کیسه صفرا درمان</a>
                            <a href="tag/درد+کیسه+صفرا+بعد+از+عمل.html" style="font-size:1em">	درد کیسه صفرا بعد از عمل</a>
                            <a href="tag/اس+ام+اس+خداحافظی.html" style="font-size:2em">	اس ام اس خداحافظی</a>
                            <a href="tag/اسپری+تاخیری.html" style="font-size:1.25em">	اسپری تاخیری</a>
                            <a href="tag/روغن+زیتون+و+واژن.html" style="font-size:1em">	روغن زیتون و واژن</a>
                    </div>
    

    
		
            <div class="nav">
            <h2><div>آمار وبلاگ</div></h2>
            کل بازدید : <script>getStatVar('total_view');</script>            <br>
            بازدید امروز :<script>getStatVar('today_view');</script>            <br>
            بازدید دیروز : <script>getStatVar('yesterday_view');</script>            <br>
            بازدید این ماه : <script>getStatVar('this_month_view');</script>            <br>
            بازدید ماه قبل : <script>getStatVar('last_month_view');</script>            <br>
            تعداد نویسندگان : <script>getStatVar('total_author');</script>            <br>
            تعداد کل پست ها : <script>getStatVar('total_post');</script>            <br>
            آخرین بازدید : <script>getStatVar('last_view_date');</script>            <br>
            آخرین بروز رسانی : <script>getStatVar('modify_date');</script>        </div>
        <br>
    <br>
    <div align="center" >
        <a href="http://www.admin.mihanblog.com"><img src="http://www.mihanblog.comhttp://mihanblog.com/public/public/images/logo/poweredby.gif" alt="Admin Logo" style="border:0px"/></a>
        <br>
        <a href="http://www.themebox.mihanblog.com"><img src="http://mihanblog.com/public//public/user_data/user_files/97/289651/logo.jpg" alt="themebox Logo" style="border:0px"/></a>
        <br>
        <div align="center" ></div>
        <br>
        <br>
        <br>
    </div>
</div>
</div>
</div>
<div class="btmborder"></div>
<div class="footer">POWERED  BY <font style="color:#f00;font-size:14px">M</font>IHAN <font style="color:#f00;font-size:13px">B</font>LOG.COM . created by: <a href="http://www.themebox.mihanblog.com"><b>ThemeBox</b></a></div>
</div>






</body>
</html><script>
//    setTimeout(function () {
//        GetMihanBlogShowAds();
//    }, 1000);
</script>
<!--NEW SERVER-->

<!--SabaVision Ads Handler--><!--<script type="text/javascript">(function (d) {var url =   location.protocol+'//api.sabavision.com/pox/poxjs.js';d.write('<script type="text/javascript" src="' + url + '" async></scri' + 'pt>');})(document);</script>-->


<script type="text/javascript">

    var _gaq = _gaq || [];
    _gaq.push(['_setAccount', 'UA-153829-9']);
    _gaq.push(['_setDomainName', 'sookootshab.mihanblog.com']);
    _gaq.push(['_trackPageview']);

    (function() {
        var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
        ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
        var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
    })();

</script>


<div id='mediaad-Kvcm'></div>
<meta name="sabavision_zone" content="2500-Z499" />
<center>
    <div style="background-color:white;width:90%;padding:20px;margin-top:50px;margin-bottom:50px;">
        <a href="https://www.cloob.com">شبکه اجتماعی فارسی کلوب</a> | <a href="https://www.targetedwebtraffic.com" target="_blank">Buy Website Traffic</a> | <a href="https://www.seo25.com" target="_blank">Buy Targeted Website Traffic</a>
    </div>
</center>
